Delivery Order SPE2DB22D3019-SPE2DB25FK3GT

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,492.67, is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90 count packages. The contract has a period of performance through July 9, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,531.89 firm-fixed-price contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets, with a performance period through January 2, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,308.36, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of January 8, 2025 and is structured as a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,880.39 firm fixed-price contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of July 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $6,087.44 and a period of performance through April 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.36 firm fixed-price contract is for the supply of Valsartan-HCTZ 160-25 mg tablets. The award is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,599,043 units of the pharmaceutical product Valsartan-HCTZ 80-12.5 mg tablets in 90-count packages. The fixed-price contract has a period of performance through August 28, 2024, and a ceiling value of $7,795.37. This delivery order is placed under a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,138.93 firm fixed price contract is for the supply of Valsartan-HCTZ 160-25 mg tablets, with a completion date of March 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The firm-fixed-price contract has a ceiling value of $17,503.46 and a period of performance through May 14, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to the pharmaceutical distributor Amerisourcebergen Drug Corporation. The $2,446.67 fixed-price contract is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK3GT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,776.80, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order does not have a set-aside designation, indicating open competition. This contract award demonstrates AmerisourceBergen's extensive experience and capabilities in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other medical supplies, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/16/25, 10:52 AM